Chordate Medical is a medical technology company that has developed, patented and CE-marked a neuromodulation and drug-free treatment technology for chronic migraine and chronic nasal congestion (rhinitis), Ozilia™ Migraine. The treatment has clinically proven efficacy according to a recent study, and is marketed in selected markets in the EU and the Middle East. Chordate Medical is listed on Nasdaq First North Growth Market Stockholm.


Health Care

Medical Devices

Therapeutics

Chordate Medical AB

Anders Weilandt

Tommy Hedberg

Henrik Rammer

Caroline Lundgren Brandberg

Alain Durante

Niklas Lindecrantz

Chordate Medical AB

Org chart

Similar companies